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Abbreviations
Hb Haemoglobin; KCH Kilifi County Hospital; mps malaria 
parasites; MUAC mid-upper arm circumference; RCT randomised 
controlled trial; OR Odds ratios; rbc red blood cells; sSA sub- 
Saharan Africa; wbc white blood cells; WHZ Weight for Height 
Z score; WHO World Health Organization.
Introduction
Transfusion of blood can be a life-saving intervention, and pro-
vision of adequate supplies of safe blood for transfusion are 
an essential undertaking for any health system. Issues of blood 
safety, adequate supply, equitable access and rational use, however, 
remain key challenges throughout the world. In resource-limited 
countries in sub-Saharan Africa (sSA) these issues present major 
barriers to the development of successful nationally-coordinated 
blood transfusion services1. The World Health Organization 
(WHO) Global Database on Blood Safety reports a mismatch 
between supply and demand. For example, the 2016 WHO survey 
found that of the 46 countries reporting from the WHO African 
Region, (which are home to approximately 13% of the global 
population) overall they collected a total of approximately 
5.6 million blood donations, which accounted for only 4% of 
global donations2. In an earlier report the average blood dona-
tion rate was 2.3/1000 population in countries with a low human 
development index in comparison to 36.7 in countries with a high 
human developmental index (HDI)2,3. The figure for the Africa 
Region (excluding South Africa) is only 3.4/1000 compared to 
the WHO estimated optimal requirement of 10-20/10004.
In order to bridge the major gap between supply and demand, 
one of the four key goals, mandated in a WHO resolution on an 
integrated strategy of blood safety in 1975 was to ‘reduce unnec-
essary transfusions’ through the more effective clinical use of 
blood and the use of simple alternatives to transfusion (such as 
crystalloids and colloids) where possible5. WHO has subsequently 
developed and published guidelines for the appropriate use of 
blood for patient groups suffering the greatest supply shortages6,7. 
Notably, the pattern of blood utilisation in sSA is very different 
from that in high HDI nations, where elective-use predominates 
and where supply is strictly monitored through specialist trans-
fusion services. By contrast, the 2016 WHO survey on world 
safety and availability of blood transfusions found that in low-
and-middle-income countries, 67% of transfusions are received by 
children under 5 years old, followed by women for pregnancy-
related complications2 with most being given as emergency 
interventions8.
What is already known?
For paediatric transfusion, the WHO conservative policy reserves 
blood transfusion for children with a Hb <4g/dl or for those with 
an Hb <6g/dl if accompanied by life-threatening complications6,7. 
These specific recommendations have not been systematically 
evaluated. Consequently, compliance is often poor and many chil-
dren receive unwarranted transfusions9,10. Nevertheless, adverse 
outcomes following admission to hospital with severe anaemia 
in children are common, with case-fatality rates being high both 
within-hospital (9–10%)11 and within 6-months of discharge 
(12%)12, in common with rates of relapse or re-hospitalisation 
(6%)12. Such data suggest that current recommendations and 
management strategies may not be working in practice. Although 
the conservative WHO transfusion guidelines were developed to 
protect scarce resources, little research has since been conducted 
to either support or challenge the haemoglobin thresholds for 
administering a transfusion. With this in mind, we have conducted 
a retrospective analysis of mortality outcome by Hb level at admis-
sion in an unselected paediatric population admitted to a rural 
district hospital in Kenya over an 8-year period. Secondary aims 
were to examine whether outcome (survival) was influenced 
by malaria infection and/or transfusion.
Methods
The study was conducted on the paediatric wards at Kilifi County 
Hospital (KCH), a rural district hospital on the coast of Kenya, 
where a system of routine surveillance has been operated by 
the KEMRI-Wellcome Trust Research Programme since 1989. 
All children <15 years of age on admission to KCH were assessed 
by a clinician. Standardised clinical proforma are entered directly 
onto a computerized database. In addition, all patients were 
investigated with a standard set of laboratory tests including 
a full blood count, a blood culture and a blood film for malarial 
parasites. HIV status was tested following parental assent. At 
discharge (or in fatal cases) the clinician completed a standard 
summary onto the computerized database which included dis-
charge diagnosis and whether a blood transfusion had been given. 
Blood transfusion policy at KCH follows WHO guidelines.
All admission records for the 8-year period January 2002 to 
September 2009 were included in the current analysis. Through-
out this period a single method for Hb measurement (Coul-
ter counter, Coulter Electronics) was used thus minimising 
potential methodological variation. Clinical data on key variables 
were retrieved together with the key co-morbidities, including 
bacteraemia, malarial parasitaemia and nutritional and HIV status, 
the receipt of a whole blood transfusion during admission 
and discharge status (alive or dead).
Data analysis
Our analysis included data from 36,621 consecutive admissions 
to the KCH paediatric ward (See Figure 1: Study Flow). Patients 
with missing data on the primary exposure (admission Hb); 
1,482 observations, 4.0%) or on the primary outcome (in-hospital 
mortality as defined by status at discharge; 208 observa-
tions, 0.1%) were excluded from the analysis. Infants under 60 
days (6,285 observations, 17%) and cases with a Hb well out-
side the normal range, >19.0 g/ld. (240, 0.1%) were excluded. 
With these adjustments, 29,226 patients remained for analysis. 
Z-scores for the anthropometric parameters weight-for-age 
(WAZ) were calculated for each individual using Epi Info 
v2000 (CDC, Atlanta) and undernutrition defined as a WAZ of 
<-3 while severe malnutrition was defined as a mid-upper arm 
circumference (MUAC) of <11.5cm. Dichotomous and categori-
cal variables were created from continuous variables. Shock was 
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Figure 1. Study flow.
defined on the basis of one or more of the following clinical 
features: capillary refill time >2 seconds; weak pulse or a tem-
perature gradient in the lower limbs (defined as a temperature 
cline detected when running the back of the hand down from 
thigh to shin). We also examined whether the clinicians were 
compliant with WHO guidelines for transfusion. Compliance 
was considered using only the features from admission. The 
WHO restricts transfusion to those with Hb <4g/dl or for 
those with an Hb <6g/dl if accompanied by life-threatening 
complications or severity features (any one of shock (any fea-
ture of delayed capillary refilling time more than 2 seconds, 
weak pulse or cold extremities (temperature gradient, severe 
dehydration (sunken eyes or decreased skin turgor), impaired 
consciousness (prostration or coma (inability to localise a 
painful stimulus), respiratory distress or high parasitaemia at 
admission).
Odds ratios (OR) for mortality in patients with an Hb below 
(exposed group) versus those with an Hb equal to or above (unex-
posed) specific thresholds, determined depending on the presence 
or absence of additional clinical features, were assessed using 
logistic regression and adjusted for malaria and transfusion 
status to examine the risk of in-hospital death by level of 
Hb at admission. All analyses were conducted using STATA 
Version 11 (Stata Corporation, Texas, USA).
Results
A total of 29,226 patients were included for analysis. Baseline 
characteristics are described by age group (Table 1) and by the 
severity of anaemia (Table 2). At admission, 1,143 (3.9%) had 
profound anaemia (Hb <4g/dl); 2,326 (7.1%) had severe anaemia 
(Hb 4- < 6.0 g/dl) and almost one third (9,457) had moderate 
anaemia (6.0-8.9 g/dl). The admission cohort included 5,914 
(20.2%) children with malnutrition described by weight for age 
<-3; alternatively 4,175/28,734 (14.6%) by mid-upper arm cir-
cumference (MUAC) <11.5 cm. The majority of children (58.8%) 
were febrile (axillary temperature >37.%C: measured by dig-
ital thermometer) at presentation. Clinical pallor defined by 
examination of conjunctiva, nail bed and palms of hands or soles 
of feet was present in 95% of children with profound anaemia 
(Hb<4g/dl); 77% with Hb 4-6g/dl, and 19% of children Hb>6g/dl 
(Table 2); jaundice was uncommon (1.9%).
Deep ‘acidotic’ breathing and/or indrawing (respiratory distress) 
were present in 3,104/29,180 (10.6%) and 7,338/29,183 (25.1%), 
respectively. Respiratory distress was associated with higher 
case fatalities 487/3104 (15.7%) and 575/7,338 (7.8%), respec-
tively, compared to 1053/26,076 (4.0%) or 966/21,845 (4.4%) in 
children without either of these signs. Notably few had hypox-
aemia (defined as a pulse oximetry (pSO2) reading of less that 
90%) present in on 118/1143 (10.3%) in children with profound 
anaemia. Clinically-defined shock was present in 4,879 (16.7%) 
and was associated with a higher fatality 612 (12.5%) compared 
to those without shock 927/24,300 (3.8%). Overall, 1,249/27909 
(4.5%) children had culture-proven bacteraemia, with a case fatal-
ity exceeding 20% (Table 1). In children with profound anae-
mia and severe anaemia 47% and 53% were malaria-parasite 
positive; however overall mortality was lower, relative to other 
co-morbidities with 280 deaths (case fatality rate, 3.6%). HIV 
status (antibody) data are less reliable owing to the large number 
of missing data (17,974 (61.5%)).
Compliance with WHO guidelines
Overall, compliance with WHO transfusion guidelines was 
good, especially with respect to transfusions given to children 
with an admission Hb >6g/dl, which occurred in only 520/24372 
(2.1%). For those with Hb< 4gdl (n=1134), 912 (80%) were 
transfused (Table 3). Children with an admission Hb 4-6g/dl, 
which included 1629/27,904 (5.8%) of children at hospital 
admission, 1564 (5.6%) of all admissions met the severity crite-
ria to transfuse, but only 567 (36.3%) were transfused and 746 
did not met severity criteria yet 194 (26% of this category) were 
transfused (Table 3). The reasons for transfusion or no transfusion 
were not systematically captured on the database.
Mortality by severity of anaemia
Profound anaemia (Hb<4g/dl) was associated with the high-
est fatality 97/1,143(8.5%) compared to 164/2,326 (7.1%) 
with severe anaemia (Hb ≥4.0-<6g/dl); 627/9,457 (6.6%) with 
moderate anaemia (≥6.0-<9.0 g/dl) and 660/16,300 (4.0%) with-
out anaemia (Hb≥9g/dl) (Table 1). The increased risk of mortal-
ity in comparison to children with a higher admission Hb level 
was greatest (OR=1.70; 95%CI: 1.37-2.11) among children with 
profound anaemia (Hb<4g/dl). The strength of this association 
was less apparent when comparing the probability of death across 
the anaemia subgroups, for example profound anaemia vs severe 
anaemia (P=0.13) and in severe anaemia vs moderate anaemia 
(P=0.80).
We therefore conducted an in-depth examination of the risk of 
fatal outcome for each stratum of Hb level compared to all Hb’s 
above that stratum in an attempt to validate the current haemo-
globin thresholds for transfusion (Figure 2). Overall, children with 
a Hb of <3g/dl were at significantly higher risk of death 
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N (%) N = 1143 (3.9) N =2326 (8.0) N = 25,757 (88.1) N = 29226

























Sex Males (%) 603 (52.8) 1282 (55.1) 14483 (56.2) 16368 (56.0)
Fever: axillary temp ≥37.5C 591 (51.8) 1454 (62.5) 15137 (58.8) 17182 (58.8)
Pallor 1086 (95.0) 1796 (77.2) 4967 (19.3) 7849 (26.9)
Visable Jaundice 55 (4.8) 124 (5.3) 370 (1.4) 549 (1.9)
WAZ ≤ -3a 354 (31.0) 667 (28.7) 4893 (19.0) 5914 (20.2)
MUAC ≤11.5 cmb 213 (18.6) 427 (18.4) 3555 (13.8) 4195 (14.4)
Weak pulse volume 163 (14.3) 143 (6.2) 1051 (4.1) 1357 (4.6)
Tachycardia13 115 (10.1) 412 (17.7) 3884 (15.1) 4411 (15.1)
Capillary refill time ≥3s 300 (26.3) 283 (12.2) 1136 (4.4) 1719 (5.9)
Temperature gradient 245 (21.4) 419 (18.0) 3563 (13.8) 4227 (14.5)
Strict shock definitionc 35 (3.1) 13 (0.6) 94 (0.4) 142 (0.5)
Severe dehydrationd 81 (7.1) 200 (8.6) 3967 (15.4) 4248 (14.5)
Indrawing 279 (24.4) 545 (23.4) 6514 (25.3) 7338 (25.1)
Deep breathinge 252 (22.1) 350 (15.1) 2502 (9.7) 3104 (10.6)
Hypoxaemia(pulse oximetry) 
Oxygen saturation <90% 118 (10.3) 138 (5.9) 1232 (4.8) 1488 (5.1)
Base excess <-8f 383 (52.2) 547 (35.1) 5632 (39.9) 6562 (40.0)
Conscious levelg 
   Alert/Normal 













High malaria parasitaemiah 539 (47.2) 1252 (53.8) 6104 (23.7) 7895 (27.0)
HIV antibody positivei 17/223 (7.6) 52/446 (11.7) 524/6811 (7.7) 593/7480 (7.9)
Pathogenic bacterial isolate 63 (5.5) 172 (7.4) 1023 (4.0) 1258 (4.3)
aWAZ: weight for age Z-score
bMUAC: mid-upper arms circumference
cPresence of weak pulse volume & capillary refill time ≥3s & temperature gradient
dPresence of sunken eyes of decreased skin turgor
eKussmaul’s breathing
fExcludes missing observations (for base excess: number of missing observations = 12819 (43.9%), for conscious 
level: number of missing observations = 3992 (13.7%)
gProstration: inability to sit upright (if >8months) or feed; coma failure to localise a painful stimulas
jhyperparasitaemia defined as:
percentage_parasitaemia= (malaria parasites (mps) per 100 white blood cells (wbc)/100)*wbc*1000 >10, or as 
percentage_parasitaemia= (mps500 red blood cells (rbc)/500)*rbc*1000000 >10
iExcluding cases that were not tested, discordant, and missing observations (number excluded = 21746 (74.4%))
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Figure 2. Odds of mortality by haemoglobin (Hb) level status.
Table 3. Receipt of transfusion according to World Health Organization transfusion (WHO) criteria.
WHO Criteria Category Freq. (%) Transfused (%) Numbers transfused in sub-category (%)
Eligible for transfusion Hb < 4 1134 (4.1) 912 (80.4) 1479 (54.8)
Hb 4-6: Criteria +ve 1564 (5.6) 567 (36.3)
Ineligible for transfusion Hb 4-6: Criteria -ve 746 (2.7) 194 (26.0) 714 (2.8)
Hb > 6 24372 (87.3) 520 (2.1)
Criteria +ve includes any one of
   •   Clinically detectable dehydration
   •   Shock (compensated)
   •   Impaired consciousness
   •   Deep breathing
   •   Very high parasitaemia
Criteria – ve includes none of the above
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compared to those with a higher admission Hb (OR= 2.41 
(95%CI: 1.8 - 3.24; P<0.001). Conversely, the risk of death 
with a Hb 3-3.9g/dl compared to those with a higher Hb was 
less pronounced OR=1.12 (95%CI: 0.96 - 1.31; P=0.13). Simi-
larly, children who fall within the classification of severe or 
moderately-severe anaemia had very little variation in their risk 
of mortality across the whole range of haemoglobins from 4.0 to 
9.9g/dl.
Outcome in relation to malaria
We analysed the risk of mortality separately for children with 
Plasmodium falciparum malaria versus non-malarial (blood slide-
negative) admissions (Table 4a, Table 4b and Figure 3). There 
were substantial differences in the patterns of risk by haemoglobin 
level. Among children with malaria parasitaemia, the greatest 
risk of death was at Hb’s of <3g/dl (OR=6.36, 95%CI: 4.21–9.62) 
compared to children with higher Hb’s, whereas the risk was less 
marked at an Hb level of 3-3.9g/dl compared to children with 
higher haemoglobins (OR=1.33, 95%CI: 1.06–1.69; P=0.02). 
Mortality was only marginally increased across Hb values between 
4 and 5.9.
The picture was different in those without malaria parasites in 
which risk of mortality was not clearly related to the severity of 
anaemia - mortality in those with Hb <3g/dl was 22/271 (8.1%) 
rising to 126/1052 (12%) in those with Hb 6.0-6.9 g/dl. The 

















<3 266 20 54 4 7.4% 212 16 7.55% 1.02 (0.33 - 3.19) 0.972
3-3.9 323 23 64 5 7.8% 259 18 6.95% 0.88 (0.31 - 2.47) 0.81
4-4.9 436 40 214 15 7.0% 222 25 11.26% 1.68 (0.86 - 3.29) 0.127
5-5.9 586 61 483 34 7.0% 103 27 26.21% 4.69 (2.68 - 8.22) <0.001
6-6.9 1013 121 931 85 9.1% 82 36 43.90% 7.79 (4.77 - 12.71) <0.001
7-7.9 1884 180 1,815 142 7.8% 69 38 55.07% 14.44 (8.72 - 23.91) <0.001
8-8.9 3154 209 3,090 173 5.6% 64 36 56.25% 21.68 (12.93 - 36.36) <0.001
9-9.9 4316 192 4,267 169 3.96% 49 23 46.94% 21.45 (11.99 - 38.38) <0.001
10-10.9 4115 142 4,074 129 3.2% 41 13 31.71% 14.20 (7.19 - 28.05) <0.001
>=11 4171 193 4,128 174 4.2% 43 19 44.19% 17.99 (9.67 - 33.47) <0.001
Total 20264 1181 19120 930 4.9% 1144 251 21.9%
Diagnoses for those with Hb 8.0g and above (tables 3a and b) who were transfused: 
Congenital abnormality (5); cerebral palsy (3); gastroenteritis (18); hepatitis (3), HIV (22); hypersplenism (1); Lower respiratory tract infection (18); malaria (45); 
















<3 169 29 38 8 21.1% 131 21 16.0% 0.72 (0.29 - 1.78) 0.471
3-3.9 366 20 62 5 8.1% 304 15 4.9% 0.59 (0.21 - 1.69) 0.328
4-4.9 552 24 250 5 2.0% 302 19 6.3% 3.29 (1.21 - 8.94) 0.02
5-5.9 657 36 479 16 3.3% 178 20 11.2% 3.66 (1.85 - 7.24) <0.001
6-6.9 795 25 721 16 2.2% 74 9 12.2% 6.10 (2.59 - 14.35) <0.001
7-7.9 948 20 911 17 1.9% 37 3 8.1% 4.64 (1.30 - 16.59) 0.018
8-8.9 1123 31 1,099 29 2.6% 24 2 8.3% 3.35 (0.75 - 14.94) 0.112
9-9.9 1186 34 1,169 28 2.4% 17 6 35.3% 22.23 (7.68 - 64.35) <0.001
10-10.9 941 15 930 15 1.6% 11 0 0.00% -
>=11 656 22 649 21 3.2% 7 1 14.3% 4.98 (0.57 - 43.27) 0.145
Total 7393 256 6308 160 2.5% 1085 96 8.8%
CI confidence interval 
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Figure 3. Odds of mortality by haemoglobin (Hb) level among those with Plasmodium falciparum malaria (blue) and those without 
(red). Odds ratios compared risk of mortality at each Hb level to that above that specific threshold.
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Effect of transfusion on outcome
We then investigated whether mortality risk was affected by the 
receipt of a transfusion during admission (Table 4a & Table 4b). 
In those with malaria (Table 4a), compared children who were not 
transfused, receipt of a transfusion appeared to improve survival 
for those with Hb <4g/dl but the confidence intervals were very 
wide (and included a possibility of harm) owing to small num-
bers. For all Hb levels above 4g/dl our analysis indicates that 
mortality was significantly higher in those receiving a transfusion 
compared to the non-transfused group (Table 4a).
For non-malarial cases (Table 4b), the receipt of a transfu-
sion did not appear to result in a survival benefit irrespective of 
baseline haemoglobin level compared to children who were 
not transfused. Children with Hb ≥8g/dl had a substantially 
increased risk of mortality if transfused; however, this included a 
heterogeneous group of children in whom the underlying dis-
ease or cause of admission was an important determinant of their 
outcome (foot of Table 4b).
Finally, we examined whether the addition of clinical signs of 
severity (deep acidotic breathing and/or altered consciousness 
(prostration or coma)) were useful in identifying particularly 
high-risk groups in whom the receipt of a transfusion may be 
of benefit (Table 5). Overall this group had a much higher mor-
tality, and whilst the receipt of a transfusion may have improved 
survival for those with a Hb of <5g/dl numbers were too small 
to show a statistical difference. For those with a Hb ≥5g/dl and 
signs of severity, transfusion was associated with a substantially 
increased risk of mortality (Table 5).
Discussion
We have shown in a retrospective analysis of 29,226 unselected 
children admitted to hospital on the coast of Kenya that the burden 
of moderate and profound or severe anaemia is substantial, 
affecting 15.8% of all admissions over 60 days of age, and that 
it carries a higher risk of in-hospital mortality (6.7–7.6%) com-
pared to children with admission Hb >9g/dl (4%). The Hb level 
associated with the highest case fatality was different in children 
with malaria (all levels below Hb 3g/dl, 17.5%) in comparison 
to those without malaria (maximal at Hb 6-7g/dl; 12%). Receipt 
of a whole blood transfusion was associated with improved 
survival in malarial cases but only at admission Hb levels of <4g/dl, 
whereas transfusion in non-malaria cases did not appear to 
improve survival, irrespective of haemoglobin level, although 
causality cannot be inferred. These data are important when con-
sidering the current WHO recommended transfusion thresh-
olds, especially for parts of sSA where malaria has declined or 
is of less public health consequence and where reconsidera-
tion of the current guidelines may be warranted. Whilst our data 
provide support for the current recommendations and indicate 
that it may be too soon to amend these, in non-malarious areas 
there are a number of notable limitations in both the evidence- 
base for the current guidelines and potential biases within our 
findings.
Overall, our findings were that at our centre compliance with 
WHO transfusion guidelines was good, specifically only 2.1% 
of children with with admission Hb >6g/dl received a transfu-
sion. This may have been due to the availability of repeated 
measures of Hb post admission to monitor children. This finding 
contrasts for other reports where adherence to transfusion guide-
lines were not followed9,10, since many transfusions initiated 
solely for severe pallor, a sign with poor specificity14.
Earlier studies have relied on small samples and included little 
information on confounders, thus limiting the generalizability of 


















<3 135 30 30 9 30.00% 105 21 20.0% 0.58 (0.23 - 1.46) 0.249
3-3.9 167 22 32 6 18.75% 135 16 11.9% 0.58 (0.21 - 1.63) 0.304
4-4.9 215 32 70 11 15.71% 145 21 14.5% 0.91 (0.41 - 2.01) 0.812
5-5.9 252 40 137 13 9.49% 115 27 23.5% 2.93 (1.43 - 5.99) 0.003
6-6.9 306 60 247 37 14.98% 59 23 39.0% 3.63 (1.93 - 6.80) <0.001
7-7.9 410 66 377 51 13.53% 33 15 45.5% 5.33 (2.53 - 11.23) <0.001
8-8.9 533 72 504 57 11.31% 29 15 51.7% 8.40 (3.86 - 18.31) <0.001
9-9.9 624 71 608 63 10.36% 16 8 50.0% 8.65 (3.14 - 23.85) <0.001
10-10.9 601 61 585 53 9.06% 16 8 50.0% 10.04 (3.62 - 27.83) <0.001
>=11 654 93 634 83 13.09% 20 10 50.0% 6.64 (2.68 - 16.43) <0.001
Total 3897 547 3224 383 11.9% 673 164 24.4%
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case fatality from malarious areas in sSA and found wide vari-
ations in outcome. The mean in-hospital case-fatality rate for 
severe anaemia (Hb <5 or <6g/dl depending on study defini-
tion) was 9% (range 4–39%). While mortality was significantly 
higher in children with a Hb <5g/dl (pooled RR=1.92 vs >5g/dl, 
95% CI 1.7–2.2), evidence for an increased risk with less severe 
anaemia was not conclusive: although the risk of death was 
increased for a Hb <8g/dl, the confidence intervals were wide11. 
The heterogeneous group of children included and outcomes 
observed also make it difficult to draw specific conclusions. 
Our study included an unselected paediatric hospital cohort and 
included data on clinical severity and co-morbidities. As such 
the cohort represents a typical paediatric population in malaria-
endemic African hospitals. A further strength of our study is that it 
was conducted in a setting where clinicians were largely compli-
ant with WHO transfusion guidelines. For example, for children 
with a Hb >6g/dl at hospital admission only 520/24372 (2.1%) 
received a transfusion, and overall 67% of transfusions given 
were ‘’appropriate’ but this was only judged from admission cri-
teria, the number subsequently developing severe and compli-
cated anaemia, particularly in those with Hb 4-6g/dl admission is 
unknown. Overall, for children who did not meet the criteria for 
transfusion according to the guidelines (at admission), only 2.8% 
(714) received a transfusion this compares very favourably with 
51% at a hospital 60 km away in Mombasa, which report over a 
similar time period where 51% of children who received transfu-
sion who did not met WHO guidelines15. In the TRACT trial, in 
children with severe uncomplicated anaemia (Hb 4-6g/dl) who 
were not randomised to receive an immediate transfusion, close 
clinical and Hb monitoring for de novo development of signs 
of severity or haemoglobin drops to < 4g/dl demonstrated that 
386/787 (49%) of children developed severe and complicated 
anaemia, 295 of these were due to drops in the Hb < 4g/dl16.
What new knowledge this study contributes
Our current analyses indicate that for children with malaria there 
may be a benefit of transfusion for those with profound anae-
mia in terms of short-term outcome (in-hospital mortality). 
However, for hospital admissions without malaria the receipt 
of a transfusion may not be beneficial irrespective of haemo-
globin levels including children with profound malarial anaemia. 
The major limitation of these types of analyses, whilst informa-
tive about which groups to target for further evaluation of clinical 
practice, the nature of the design precludes any inference of cau-
sality – which can only reliability be tested in a clinical trial. 
For example, children with a higher admission Hb (>8g/dl) 
transfusion appeared to be associated with a substantially worse 
outcome. Exploring the final diagnoses of this group reveals 
that it includes a large number of children with underlying 
co-morbidities associated with a substantially worse outcome 
including malignancies, HIV infection, severe malnutrition and 
trauma (see Table 2b).
In current guidelines, it is recommended that wherever possi-
ble, simple alternatives to transfusion (such as crystalloids and 
colloids) should be used to avert unnecessary transfusion in 
emergencies. However, a large paediatric controlled trial of fluid 
resuscitation (FEAST trial) examining boluses of 20–40mls/kg 
of 0.9% saline and 5% human albumin in African children with 
shock, including 987 (32%) with severe anaemia (Hb <5g/ld.) 
demonstrated a 3.3% increased absolute risk of death by 48-hours 
(primary outcome) in the bolus-arms compared with controls (no 
bolus fluid strategy)13. Excess mortality in bolus arms was 
evident in children without severe anaemia (Hb ≥5g/ld.; rela-
tive risk 1.31 (95% confidence interval 0.93-1.84)) as well as 
those severe anaemia (Hb <5g/ld.; RR 1.71 (1.16-2.51)) with no 
apparent heterogeneity between these sub-groups (p=0.31)13. 
For the conditions studied in the trial, largely malaria and 
sepsis, these challenge current fluid management guidelines for 
children with shock but are also relevant to the recommendation 
for use of alternatives to transfusion.
The conservative transfusion guidelines were developed to pro-
tect scarce resources, avert overuse, and reduce the risk of 
transfusion-transmissible infections. However, in recent years 
considerable progress on strengthening transfusion services, and 
improving the supply and safety of transfusion through estab-
lishment of regional centres to replace hospital-based systems 
and by providing quality assurance for viral testing17. Thus, the 
capacity of transfusion services to provide blood has greatly 
increased due to year-on-year declines in the intensity of malaria 
transmission that have led directly to reductions in hospitalisa-
tion of children with malaria, and indirectly to reduced utilisa-
tion of blood transfusion services18. The reduction in the burden 
of malaria19, coupled with continued poor outcomes from severe 
anaemia irrespective of malaria incidence, are a good starting 
point from which to now advocate for re-evaluation of transfusion 
guidelines in order to generate an evidence base for clinical 
practice. Such evaluation is particularly pertinent given that cur-
rent recommendations were designed for areas with a high propor-
tion of malaria-associated anaemia as opposed to severe anaemia 
secondary to other aetiologies where mortality appears to 
be much higher13,20. We have shown previously that a reduc-
tion in the transmission intensity within Kilifi District resulted in 
a substantial decline in malaria and paediatric admissions to the 
Kilifi County Hospital21. Concurrent with this epidemiological 
transition we found a sharp decline in the prevalence of severe 
anaemia as well as the number and proportion of admissions 
transfused18. Nevertheless, we found no evidence that this resulted 
in improved outcome, which remained constant over time despite 
a decrease in demand for blood on the transfusion services18.
A Cochrane review including the only two African randomised 
controlled trials22,23 conducted to date (involving 114 and 116 
children randomised to blood transfusion or oral haematinics) 
concluded that there was insufficient information on whether 
routinely giving blood to clinically stable children with severe 
anaemia either reduces death or results in a higher haematocrit 
measured at one month and indicated the need for a definitive 
trial24. A prospective, randomised, controlled, non-inferiority 
trial in relatively stable Canadian and European children 
demonstrated that a restrictive transfusion protocol (with a 
transfusion threshold <7g/dl) was as safe as a liberal protocol 
(threshold <9g/dl)25. Subsequently, practice guidelines in these 
countries have been amended to include restrictive transfusion 
(Hb<7g/dl). Worldwide consensus transfusion guidelines 
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for stable children on intensive care units, based on the TRI-
PICU trial25, recommend transfusion at haemoglobin <7g/dl26. 
However they highlight the need for further trials, particularly 
in children with haemoglobins 5–7g/dl. Of note children in 
TRIPICU were likely to have had steady-state haemoglobins 
11–14g/dl, conversely s African children living in areas where 
malaria is endemic and alpha + thalassaemia are common27 
typically have haemoglobin 9–11g/dl12,28. The apparent safety 
of not transfusion all children with lower haemoglobin in 
Africa may therefore reflect the differences in the steady-state 
haemoglobins.
Conclusions
Despite poor compliance with current guidelines outcomes 
are unsatisfactory including high rates of in-hospital mortality 
(9–10%) and in the six months following admission with severe 
anaemia both case fatality and relapse remain high (6%) thus war-
ranting a definitive trial to establish best transfusion and treatment 
strategies to prevent both early and delayed mortality and relapse. 
The Transfusion and Treatment of severe anaemia in African 
children: a randomised controlled trial (ISRCTN84086586) 
was designed to evaluate current transfusion recommenda-
tions against more liberal transfusion to improve short term and 




Figshare: Admission records, including haemoglobin meas-
urements, for 29,226 children admitted to a paediatric ward in 
a rural Kenyan hospital for the period 2002–2009, https://doi.
org/10.6084/m9.figshare.763590830
Data are available under the terms of the Creative Commons 
Zero “No rights reserved” data waiver (CC0 1.0 Public domain 
dedication).
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Yes the data sets were assembled to inform the design of the TRACT trial (and justify to
funders) - see reference to trial protocol.  The data were collected during a period when
malaria transmission in Kilifi  had transitioned from high endemicity to low (its nadir
 (ref 1 below)actually), based upon the recent paper published about severe malaria .
FEAST trial only started in 2009 and the numbers included in the trial from Kilifi were
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collected routinely were clinical data, haemoglobin, malaria slide and blood cultures. HIV
was only recorded on patients following parental assent; thus missingness in this data
field is likely to be bias the overall interpretation. Blood gases were not routinely collected














We have corrected these and rewritten the first 3 sentences to make our points clearer. 
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We agree that the looking at a Hb range over 1 gram increments is rather crude but the
numbers in each of the levels of Hb are large. We were limited in adding in too many other
variables to understand why the transfusion vs no transfusion may have had different
 outcomes as the only parameters that were collected routinely were clinical data,
haemoglobin, malaria slide and blood cultures. HIV was only recorded on patients
following parental assent; thus missingness in this data field is likely to bias the overall
interpretation as those refusing the test have been shown to have worse outcome. Blood
gases were not routinely collected and only done in children with signs of severity and at
a clinicians discretion, thus likely to bias the interpretation if this were to be included in a
multivariate analysis. Moreover, the decision to transfuse, especially in those with higher
haemoglobin were not routinely collected and thus a major limitation of this paper. The
only way to satisfactorily address whether children benifit from transfusion is through a
 clinical trial which has been conducted in those with haemoglobins below 6 g/dl (2). For
those with Hb above this level this would require a separate trial, which may be harder to
justify given the substantial burden that severe anaemia places on the transfusion











Yes, we were surprised by the poor compliance in those with Hb 4-6g/dl with current
guidelines especially those with signs of severity. Some may have been explained by
blood shortages and by the time blood became available either the child had died or
recovered- we did not record whether a transfusion was requested and not received-
something for future implementation post-TRACT trial. In the TRACT trial we did note that
49% of children with Hb 4-6 g/dl without signs of severity developed severe and
(3)complicated  anaemia later in the admission requiring blood transfusion . We have now
included this into the discussion section of the paper.
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In the controlled trial (Albumin vs Saline (Bolus) vs Control which is the reference I am
referring to only received 20-40 mls/kg only (with 40 mls/kg given only in the last 6
months of the trial, after a protocol amendment) In the stratum with hypotensive shock
only few children were enrolled (29 in total) and there was no controls in this stratum and
in reality following the protocol amendment which permitted up 60mls/kg very few
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